Pharyngitis Treatment Global Market Report 2025

Pharyngitis Treatment Global Market Report 2024

Pharyngitis Treatment Global Market Report 2025 – By Drug Class (Beta Lactams, Macrolides, Cephalosporins, Fluoroquinolones, Tetracycline, Other Drug Classes), By Source of Infection (Viral, Bacterial), By Modes Of Delivery (Oral, Intravenous, Intramuscular, Other Modes Of Delivery), By End-Users (Hospitals, Homecare, Specialty Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

Name: Pharyngitis Treatment Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Pharyngitis Treatment Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Pharyngitis Treatment Global Market Report 2025

Proud Members Of

Pharyngitis Treatment Market Definition

Pharyngitis treatment refers to the management and care provided to individuals experiencing inflammation of the mucous membranes of the oropharynx, commonly known as the throat. Pharyngitis can be caused by a variety of reasons, including bacterial or viral infections, allergies, trauma, malignancy, reflux, and some poisons.

The main drug class types of pharyngitis treatment are beta-lactams, macrolides, cephalosporins, fluoroquinolones, tetracycline and others. Beta-lactams are a class of antibiotics that contain a beta-lactam ring in their chemical structure. The various source of infection includes viral and bacterial. The various modes of delivery include oral, intravenous, intramuscular and others that are used by various end-users such as hospitals, homecare, specialty centers and others.

Pharyngitis Treatment Market Segmentation

The pharyngitis treatment market covered in this report is segmented –

1) By Drug Class: Beta Lactams, Macrolides, Cephalosporins, Fluoroquinolones, Tetracycline, Other Drug Classes

2) By Source of Infection: Viral, Bacterial

3) By Modes Of Delivery: Oral, Intravenous, Intramuscular, Other Modes Of Delivery

4) By End-Users: Hospitals, Homecare, Specialty Centers, Other End-Users

Subsegments:

1) By Beta Lactams: Penicillins, Amoxicillin, Ampicillin

2) By Macrolides: Erythromycin, Azithromycin, Clarithromycin

3) By Cephalosporins: Cefuroxime, Ceftriaxone, Cefdinir

4) By Fluoroquinolones: Ciprofloxacin, levofloxacin, Moxifloxacin

5) By Tetracycline: Doxycycline, Minocycline, Tetracycline

6) By Other Drug Classes: Clindamycin, Sulfonamides, Carbapenems

Pharyngitis Treatment Market Size and growth rate 2025 to 2029: Graph

Pharyngitis Treatment Market Size 2025 And Growth Rate

The pharyngitis treatment market size has grown steadily in recent years. It will grow from $2.27 billion in 2024 to $2.37 billion in 2025 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to high prevalence and growing incidence of flu, rising prevalence of pharyngitis, growing awareness of pharyngitis, increasing access to healthcare, rising disposable incomes.

Pharyngitis Treatment Market Growth Forecast

The pharyngitis treatment market size is expected to see strong growth in the next few years. It will grow to $2.99 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to adoption of rapid point-of-care tests, demand for personalized medicine, prevalence of antibiotic resistance, rising importance of hand hygiene. Major trends in the forecast period include advancements in research and development of pharyngitis therapies, digital health technologies, telehealth integration,.

Book your 30 minutes free consultation with our research experts

Pharyngitis Treatment Market Driver: Increasing Strep Throat Transmission Fueling Growth In The Pharyngitis Treatment Market

The rising transmission of strep throat is expected to propel the growth of the pharyngitis treatment market going forward. Strep throat is a contagious bacterial infection that primarily affects the throat and tonsils. Prompt and effective treatment of strep throat with antibiotics helps alleviate symptoms, prevent complications and reduce the risk of spreading the infection to others. For instance, in June 2022, according to the Centers for Disease Control and Prevention, a US-based government agency, every year, approximately 14,000 to 25,000 cases of invasive group A strep disease occur in the United States. Additionally, strep diseases lead to 5.2 million outpatient visits and 2.8 million antibiotic prescriptions annually. Therefore, the rising transmission of strep throat drives the pharyngitis treatment market.

Pharyngitis Treatment Market Driver: Increasing Cases Of Influenza Drive Pharyngitis Treatment Market

The growing incidence of influenza is expected to propel the growth of the pharyngitis treatment market going forward. Influenza, commonly known as the flu, is a contagious respiratory illness caused by influenza viruses. Pharyngitis treatment is primarily used to treat influenza and is helpful for the flu by relieving the symptoms, which are inflammation or irritation, and this treatment focused on relieving allergies and preventing complications such as pneumonia and bronchitis. For instance, in July 2023, according to the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency. In the 2022/2023 influenza season in the EU/EEA, the percentage of positive influenza specimens reached 42% in week 51 of 2022. Positivity then remained around 28% from week 5 to week 12 of 2023. Therefore, the growing incidence is driving the growth of the pharyngitis treatment market.

Global Pharyngitis Treatment Market Major Players

Major companies operating in the pharyngitis treatment market are Pfizer Inc., GlaxoSmithKline PLC, Genentech Inc., Pliva Hrvatska D.o.o., Viatris Inc., Teva Pharmaceutical Industries Ltd., AbbVie Inc., Medtronic PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Pliva Hrvatska D.o.o., LivaNova PLC, Genentech Inc.

Global Pharyngitis Treatment Market Trend: Advancements In Pharyngitis Treatment Focus On Oral Monotherapy For Enhanced Patient Compliance

Major companies operating in the pharyngitis treatment market are focusing on developing innovative products such as oral monotherapy to enhance patient compliance and provide effective, convenient treatment options. Oral monotherapy refers to the use of a single drug or medication administered orally (by mouth) to treat a specific condition or disease. It involves the administration of just one therapeutic agent as opposed to a combination of multiple treatments to achieve the desired therapeutic effect. For instance, in December 2023, Novartis AG, a Switzerland-based pharmaceutical corporation The FDA has granted approval for Fabhalta (iptacopan), establishing IT as the first oral monotherapy for adults with paroxysmal nocturnal hemoglobinuria (PNH). This milestone, achieved on [date], represents a significant advancement by offering a new treatment option that enhances hemoglobin levels, eliminating the need for blood transfusions.

Pharyngitis Treatment Market Merger And Acquisition: TPG Inc. Acquires Majority Stake In INova Pharmaceuticals To Expand Healthcare Portfolio

In November 2022, TPG Inc., a US-based private equity company, acquired a majority stake in iNova Pharmaceuticals for $1.3 billion (UD 2 billion). With this acquisition, TPG Inc. aims to accelerate growth, expand market reach, and enhance product offerings in the healthcare sector, particularly across Southeast and North Asia. iNova Pharmaceuticals is a Singapore-based pharmaceutical company. That provide over-the-counter products for relieving symptoms of pharyngitis, such as throat lozenges and pain relievers.

Regional Outlook For The Global Pharyngitis Treatment Market

North America was the largest region in the pharyngitis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharyngitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pharyngitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pharyngitis Treatment Market?

The pharyngitis treatment market consists of sales of antibiotics, antiviral drugs and antifungal medications. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Pharyngitis Treatment Industry?

The pharyngitis treatment market research report is one of a series of new reports from The Business Research Company that provides pharyngitis treatment market statistics, including pharyngitis treatment industry global market size, regional shares, competitors with a pharyngitis treatment market share, detailed pharyngitis treatment market segments, market trends and opportunities and any further data you may need to thrive in the pharyngitis treatment industry. This pharyngitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Pharyngitis Treatment Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$2.37 billion
Revenue Forecast In 2034	$2.99 billion
Growth Rate	CAGR of 6.0% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Drug Class: Beta Lactams, Macrolides, Cephalosporins, Fluoroquinolones, Tetracycline, Other Drug Classes 2) By Source of Infection: Viral, Bacterial 3) By Modes Of Delivery: Oral, Intravenous, Intramuscular, Other Modes Of Delivery 4) By End-Users: Hospitals, Homecare, Specialty Centers, Other End-Users Subsegments: 1) By Beta Lactams: Penicillins, Amoxicillin, Ampicillin 2) By Macrolides: Erythromycin, Azithromycin, Clarithromycin 3) By Cephalosporins: Cefuroxime, Ceftriaxone, Cefdinir 4) By Fluoroquinolones: Ciprofloxacin, Levofloxacin, Moxifloxacin 5) By Tetracycline: Doxycycline, Minocycline, Tetracycline 6) By Other Drug Classes: Clindamycin, Sulfonamides, Carbapenems
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., GlaxoSmithKline PLC, Genentech Inc., Pliva Hrvatska D.o.o., Viatris Inc., Teva Pharmaceutical Industries Ltd., AbbVie Inc., Medtronic plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals plc, Lupin Limited, Pliva Hrvatska D.o.o., LivaNova PLC, Genentech Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Pharyngitis Treatment Market Characteristics

3. Pharyngitis Treatment Market Trends And Strategies

4. Pharyngitis Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Pharyngitis Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Pharyngitis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Pharyngitis Treatment Market Growth Rate Analysis

5.4. Global Pharyngitis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Pharyngitis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Pharyngitis Treatment Total Addressable Market (TAM)

6. Pharyngitis Treatment Market Segmentation

6.1. Global Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Beta Lactams

Macrolides

Cephalosporins

Fluoroquinolones

Tetracycline

Other Drug Classes

6.2. Global Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Viral

Bacterial

6.3. Global Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Intravenous

Intramuscular

Other Modes Of Delivery

6.4. Global Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Homecare

Specialty Centers

Other End-Users

6.5. Global Pharyngitis Treatment Market, Sub-Segmentation Of Beta Lactams, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Penicillins

Amoxicillin

Ampicillin

6.6. Global Pharyngitis Treatment Market, Sub-Segmentation Of Macrolides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Penicillins

Amoxicillin

Ampicillin

6.7. Global Pharyngitis Treatment Market, Sub-Segmentation Of Cephalosporins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cefuroxime

Ceftriaxone

Cefdinir

6.8. Global Pharyngitis Treatment Market, Sub-Segmentation Of Fluoroquinolones, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Ciprofloxacin

Levofloxacin

Moxifloxacin

6.9. Global Pharyngitis Treatment Market, Sub-Segmentation Of Tetracycline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Doxycycline

Minocycline

Tetracycline

6.10. Global Pharyngitis Treatment Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Clindamycin

Sulfonamides

Carbapenems

7. Pharyngitis Treatment Market Regional And Country Analysis

7.1. Global Pharyngitis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Pharyngitis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharyngitis Treatment Market

8.1. Asia-Pacific Pharyngitis Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharyngitis Treatment Market

9.1. China Pharyngitis Treatment Market Overview

9.2. China Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharyngitis Treatment Market

10.1. India Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharyngitis Treatment Market

11.1. Japan Pharyngitis Treatment Market Overview

11.2. Japan Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharyngitis Treatment Market

12.1. Australia Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharyngitis Treatment Market

13.1. Indonesia Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharyngitis Treatment Market

14.1. South Korea Pharyngitis Treatment Market Overview

14.2. South Korea Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharyngitis Treatment Market

15.1. Western Europe Pharyngitis Treatment Market Overview

15.2. Western Europe Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharyngitis Treatment Market

16.1. UK Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharyngitis Treatment Market

17.1. Germany Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharyngitis Treatment Market

18.1. France Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharyngitis Treatment Market

19.1. Italy Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharyngitis Treatment Market

20.1. Spain Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharyngitis Treatment Market

21.1. Eastern Europe Pharyngitis Treatment Market Overview

21.2. Eastern Europe Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharyngitis Treatment Market

22.1. Russia Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharyngitis Treatment Market

23.1. North America Pharyngitis Treatment Market Overview

23.2. North America Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharyngitis Treatment Market

24.1. USA Pharyngitis Treatment Market Overview

24.2. USA Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharyngitis Treatment Market

25.1. Canada Pharyngitis Treatment Market Overview

25.2. Canada Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharyngitis Treatment Market

26.1. South America Pharyngitis Treatment Market Overview

26.2. South America Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharyngitis Treatment Market

27.1. Brazil Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharyngitis Treatment Market

28.1. Middle East Pharyngitis Treatment Market Overview

28.2. Middle East Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharyngitis Treatment Market

29.1. Africa Pharyngitis Treatment Market Overview

29.2. Africa Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharyngitis Treatment Market Competitive Landscape And Company Profiles

30.1. Pharyngitis Treatment Market Competitive Landscape

30.2. Pharyngitis Treatment Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Genentech Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Pliva Hrvatska D.o.o. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Pharyngitis Treatment Market Other Major And Innovative Companies

31.1. Teva Pharmaceutical Industries Ltd.

31.2. AbbVie Inc.

31.3. Medtronic plc

31.4. Takeda Pharmaceutical Company Limited

31.5. Eli Lilly and Company

31.6. Gilead Sciences Inc.

31.7. Amgen Inc.

31.8. Boehringer Ingelheim International GmbH

31.9. Viatris Inc.

31.10. Teva Pharmaceutical Industries Ltd.

31.11. Fresenius Kabi AG

31.12. Bausch Health Companies Inc.

31.13. Sun Pharmaceutical Industries Ltd.

31.14. Dr. Reddy's Laboratories Ltd.

31.15. Cipla Limited

32. Global Pharyngitis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharyngitis Treatment Market

34. Recent Developments In The Pharyngitis Treatment Market

35. Pharyngitis Treatment Market High Potential Countries, Segments and Strategies

35.1 Pharyngitis Treatment Market In 2029 - Countries Offering Most New Opportunities

35.2 Pharyngitis Treatment Market In 2029 - Segments Offering Most New Opportunities

35.3 Pharyngitis Treatment Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Pharyngitis Treatment Market, Sub-Segmentation Of Beta Lactams, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Pharyngitis Treatment Market, Sub-Segmentation Of Macrolides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Pharyngitis Treatment Market, Sub-Segmentation Of Cephalosporins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Pharyngitis Treatment Market, Sub-Segmentation Of Fluoroquinolones, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Pharyngitis Treatment Market, Sub-Segmentation Of Tetracycline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Pharyngitis Treatment Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Pharyngitis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Global Pharyngitis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: Asia-Pacific, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: China, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: India, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Japan, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Australia, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Indonesia, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: South Korea, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Western Europe, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: UK, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Germany, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: France, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Italy, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Spain, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Eastern Europe, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Russia, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: North America, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: USA, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Canada, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: South America, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Brazil, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Middle East, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Africa, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 81: Pfizer Inc. Financial Performance

Table 82: GlaxoSmithKline PLC Financial Performance

Table 83: Genentech Inc. Financial Performance

Table 84: Pliva Hrvatska D.o.o. Financial Performance

Table 85: Viatris Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Pharyngitis Treatment Market, Sub-Segmentation Of Beta Lactams, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Pharyngitis Treatment Market, Sub-Segmentation Of Macrolides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Pharyngitis Treatment Market, Sub-Segmentation Of Cephalosporins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Pharyngitis Treatment Market, Sub-Segmentation Of Fluoroquinolones, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Pharyngitis Treatment Market, Sub-Segmentation Of Tetracycline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Pharyngitis Treatment Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Pharyngitis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Global Pharyngitis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: Asia-Pacific, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: China, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: India, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Japan, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Australia, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Indonesia, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: South Korea, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Western Europe, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: UK, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Germany, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: France, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Italy, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Spain, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Eastern Europe, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Russia, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: North America, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: USA, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Canada, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: South America, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Brazil, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Middle East, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Africa, Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 81: Pfizer Inc. Financial Performance

Figure 82: GlaxoSmithKline PLC Financial Performance

Figure 83: Genentech Inc. Financial Performance

Figure 84: Pliva Hrvatska D.o.o. Financial Performance

Figure 85: Viatris Inc. Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

How Will The Nuclear Medicine Market Grow In 2022?

What Is The Pediatric Imaging Market Overview In 2022?

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the medical tourism market research report 2022 with industry size, share, segments and market growth

Inflammatory Bowel Disease Treatment Global Market Report 2025 – By Drug Class (Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes), By Type (Crohn's Disease, Ulcerative Colitis), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Non-Steroidal Anti-inflammatory Drugs Global Market Report 2025 – By Route of Administration( Oral, Topical, Other Route of Administration), By Disease Indication( Arthritis, Migraine, Ophthalmic Diseases, Other Disease Indications), By Distribution Channel( Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cystic Fibrosis (CF) Therapeutics Global Market Report 2025 – By Drug Class (Pancreatic Enzyme Supplements, Mucolytic, Bronchodilators, CFTR Modulators), By Route Of Administration (Oral, Inhaled), By Treatment Method (Medication, Devices) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Neurodegenerative Disorder Therapeutics Global Market Report 2025 – By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Other Indication Types), By Drug Type (N- methyl- D- aspartate Receptor, Selective Serotonin Reuptake Inhibitor, Dopamine Inhibitors, Other Drug Types), By Distribution (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Bipolar Disorder Therapeutics Global Market Report 2025 – By Drug Class (Mood Stabilizers, Antipsychotic Drugs, Antidepressant Drugs, Other Drugs), By Mechanism (Selective Serotonin Reuptake Inhibitors, Serotonin-norepinephrine Reuptake Inhibitors, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, Benzodiazepines, Beta-Blockers, Other Mechanisms), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Digital Therapeutics Global Market Report 2025 – By Product (Software, Devices), By Sales Channel (Business-To-Business (B2B), Business-To-Consumers (B2C)), By Application (Preventive Applications, Treatment Or Care-Related Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Leukemia Therapeutics Global Market Report 2025 – By Treatment Type (Chemotherapy, Immunotherapy, Targeted Therapy, Other Treatments), By Type Of Leukemia (Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Other Type Of Leukemia), By Molecule Type (Small Molecules, Biologics), By End-Users (Hospitals, Homecare, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Peptide Therapeutics Global Market Report 2025 – By Type (Generic, Branded), By Route of Administration (Parenteral, Mucosal, Oral, Transdermal), By Application (Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Pharyngitis Treatment market?

How will the Pharyngitis Treatment market drivers and restraints affect the market dynamics? What forces will shape the Pharyngitis Treatment industry going forward?

The Pharyngitis Treatment market major growth driver - Increasing Strep Throat Transmission Fueling Growth In The Pharyngitis Treatment Market. For further insights on the Pharyngitis Treatment market, request a sample here

What is the forecast market size or the forecast market value of the Pharyngitis Treatment market?

The Pharyngitis Treatment market size has grown strongly in recent years. The pharyngitis treatment market size has grown steadily in recent years. It will grow from $2.27 billion in 2024 to $2.37 billion in 2025 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to high prevalence and growing incidence of flu, rising prevalence of pharyngitis, growing awareness of pharyngitis, increasing access to healthcare, rising disposable incomes. The pharyngitis treatment market size is expected to see strong growth in the next few years. It will grow to $2.99 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to adoption of rapid point-of-care tests, demand for personalized medicine, prevalence of antibiotic resistance, rising importance of hand hygiene. Major trends in the forecast period include advancements in research and development of pharyngitis therapies, digital health technologies, telehealth integration, . For further insights on the Pharyngitis Treatment market, request a sample here

How is the Pharyngitis Treatment market segmented?

The pharyngitis treatment market covered in this report is segmented –
1) By Drug Class: Beta Lactams, Macrolides, Cephalosporins, Fluoroquinolones, Tetracycline, Other Drug Classes
2) By Source of Infection: Viral, Bacterial
3) By Modes Of Delivery: Oral, Intravenous, Intramuscular, Other Modes Of Delivery
4) By End-Users: Hospitals, Homecare, Specialty Centers, Other End-Users Subsegments:
1) By Beta Lactams: Penicillins, Amoxicillin, Ampicillin
2) By Macrolides: Erythromycin, Azithromycin, Clarithromycin
3) By Cephalosporins: Cefuroxime, Ceftriaxone, Cefdinir
4) By Fluoroquinolones: Ciprofloxacin, Levofloxacin, Moxifloxacin
5) By Tetracycline: Doxycycline, Minocycline, Tetracycline
6) By Other Drug Classes: Clindamycin, Sulfonamides, Carbapenems For further insights on the Pharyngitis Treatment market, request a sample here

Which region has the largest share of the Pharyngitis Treatment market? What are the other regions covered in the report?

North America was the largest region in the pharyngitis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharyngitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on the Pharyngitis Treatment market, request a sample here.

Who are the major players in the Pharyngitis Treatment market?

What are the key trends in the Pharyngitis Treatment market?

Major trends in the Pharyngitis Treatment market include Advancements In Pharyngitis Treatment Focus On Oral Monotherapy For Enhanced Patient Compliance. For further insights on the Pharyngitis Treatment market, request a sample here.

What are the major opportunities in the Pharyngitis Treatment market? What are the strategies for the Pharyngitis Treatment market?

For detailed insights on the major opportunities and strategies in the Pharyngitis Treatment market, request a sample here.

How does the Pharyngitis Treatment market relate to the overall economy and other similar markets?

For detailed insights on Pharyngitis Treatment's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Pharyngitis Treatment industry?

For detailed insights on the mergers and acquisitions in the Pharyngitis Treatment industry, request a sample here.

What are the key dynamics influencing the Pharyngitis Treatment market growth? SWOT analysis of the Pharyngitis Treatment market.

For detailed insights on the key dynamics influencing the Pharyngitis Treatment market growth and SWOT analysis of the Pharyngitis Treatment industry, request a sample here.